Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;44(2):57-58.
doi: 10.18773/austprescr.2021.008. Epub 2021 Feb 26.

BNT162b2 vaccine for prevention of COVID-19

No authors listed
Review

BNT162b2 vaccine for prevention of COVID-19

No authors listed. Aust Prescr. 2021 Apr.
No abstract available

PubMed Disclaimer

References

    1. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. As of 22 February 2021. https://covid19.who.int [cited 2020 Feb 23]
    1. McIntyre P, Joo YJ, Chiu C, Flanagan K, Macartney K. COVID-19 vaccines - are we there yet? Aust Prescr 2021;44:19-25. 10.18773/austprescr.2020.084 - DOI - PMC - PubMed
    1. Walsh EE, Frenck RW, Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med 2020;383:2439-50. 10.1056/NEJMoa2027906 - DOI - PMC - PubMed
    1. Sahin U, Muik A, Vogler I, Derhovvanessian E, Kranz LM, Vormehr M, et al. BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans. MedRxiv. Preprint posted December 11, 2020 [cited 2020 Feb 23]. https://doi.org/10.1101/2020.12.09.20245175 - DOI
    1. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. C4591001 Clinical Trial Group . Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603-15. 10.1056/NEJMoa2034577 - DOI - PMC - PubMed

LinkOut - more resources